Navigation Links
TriLink Enters Into Distribution Agreement With TATAA Biocenter
Date:3/28/2011

SAN DIEGO, March 28, 2011 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink) announced that it has entered into a distribution agreement with TATAA Biocenter (TATAA) to sell its CleanAmp™ Products. The Scandinavian based TATAA develops and performs a broad spectrum of hands-on qPCR courses worldwide, in addition to providing tailor-made products for real-time PCR applications.

As an innovative approach to Hot Start PCR, TriLink's CleanAmp™ Product Line is an ideal complement to TATAA's product and service offerings. In developing CleanAmp™, TriLink applied its expertise in modified nucleic acid chemistry to resolve common PCR problems, such as primer dimer formation and mis-priming. This advancement in Hot Start technology employs two widely ignored components of the PCR reagent mix: the primers and the dNTPs. The latest addition to the CleanAmp™ Product Line will be new, improved CleanAmp™ dNTPs, which will be available in April 2011. The latest advancement in CleanAmp™ dNTP chemistry allows improved amplicon yield in endpoint PCR and earlier Cq values in fast cycling real-time PCR.

"TATAA has established itself as a thought leader in the field of real-time PCR, and we are excited about the opportunity to expose our CleanAmp™ technology to the international research community through its training courses. We are confident that TATAA and its clients will be pleased with the results they see using CleanAmp™ Products," stated TriLink's President and CEO, Richard Hogrefe.

"The CleanAmp™ hot-start technique developed at TriLink is so much more versatile and easy to implement compared to alternatives, and being supported by our application specialists, we expect it will become a most popular product," says Mikael Kubista, founder and CEO of TATAA Biocenter.

About TriLink

TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products for the research, diagnostic and OEM markets. In addition, custom chemistry, contract research services and ISO/QSR compliant cGMP production facilities are offered.  TriLink's solutions help advance drug discovery and biomedical research.  Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 85 scientists and other professionals. For more information about the firm and products, call 858-546-0004, email info@trilinkbiotech.com, or visit our web site at www.trilinkbiotech.com.

About TATAA Biocenter

TATAA Biocenter is one of the leading research and service providers and organizers of hands-on training courses in qPCR in Europe. They offer a full range of real-time qPCR services including high throughput qPCR analysis, primer and probe design and validation, data analysis, testing and evaluation of kits and instruments, and contract research to Pharmaceutical and Biotech companies among others. Founded in 2001, TATAA has permanent facilities in Gothenburg, Sweden, Sunnyvale, California, and Prague, Czech Republic.

For more information about the CleanAmp™ products in Europe see www.tataa.com or contact TATAA head of sales, Ara Rofooragan (ara.rofoogaran@tataa.com, +46 (707) 731098).


'/>"/>
SOURCE TriLink BioTechnologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. TriLink BioTechnologies to Sponsor GIVING HUNGER THE BLUES, a Benefit Concert to Help Alleviate Hunger in San Diego County
2. TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services
3. TriLink BioTechnologies, Inc. Launches New Website and OligoBuilder(R)
4. TriLink BioTechnologies to Sponsor Take Me Out to the Ballgame, a SAY San Diego Event Benefiting San Diego Families in Need
5. TriLink BioTechnologies Launches CleanAmp™ 7-deaza-dGTP for GC-rich Target Amplification
6. TriLink Awarded SBIR Phase I Grant: Thermally Activatable Probes and Cofactors for Hot Start Ligase Chain Reaction
7. Chromos enters into an Arrangement Agreement
8. American Laser Centers Opens Three Minneapolis-St. Paul Area Clinics
9. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
10. Melior Enters Research Collaboration with AstraZeneca
11. Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the Worlds First Adaptive 128-slice CT Scanner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 2016 MedGenome,s Commitment Will ... Understanding of Complex Diseases Such as Cancer, Metabolic ... --> --> MedGenome, the ... a leading provider of genomics research services globally, ... the GenomeAsia 100K consortium as a founding member. ...
(Date:2/11/2016)...  Vermillion, Inc. (NASDAQ: VRML ), a bio-analytical ... formation of the Steering Committee for its Pelvic Mass ... Pelvic masses can present physicians and healthcare professionals ... is ruled out, pelvic masses may include cancers of ... ovarian tumors and gastrointestinal and urinary tract masses. ...
(Date:2/11/2016)... 2016  Spectra BioPharma Selling Solutions (Spectra) is ... biopharma companies the experience, expertise, operational delivery and ... sales teams. Created in concert with industry leading ... strategic and tactical needs of its clients by ... both personal and non-personal promotion. ...
(Date:2/11/2016)... 11, 2016  Dovetail Genomics™ LLC today announced that ... for a planned metagenomic genome assembly service. Richard ... genome assembly method in a talk on Friday, February ... Technology conference in Orlando, Fla. ... datasets is difficult. Using its proprietary Chicago ...
Breaking Biology Technology:
(Date:2/9/2016)... , Feb. 9, 2016 Vigilant Solutions announces today ... reader (LPR) to develop a lead in a difficult homicide ... LPR data to locate the suspect vehicle. Due to the ... case have been omitted at the agency,s request. ... agency explains, "Our victim was found deceased at an intersection ...
(Date:2/3/2016)... -- --> --> ... Identification System Market by Component (Hardware and Software), Search ... Government, Healthcare, and Transportation) and Geography - Global Forecast ... to be worth USD 8.49 Billion by 2020 at ... The transformation and technology evolution from the manual process ...
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
Breaking Biology News(10 mins):